Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
About this item
Full title
Author / Creator
Publisher
Schiphol: Bentham Science Publishers Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Schiphol: Bentham Science Publishers Ltd
Subjects
More information
Scope and Contents
Contents
Aberrant signaling caused by mutations in the RAS-RAF-MEK-ERK pathway and its upstream activators critically contributes to human tumor development. Strategies, which aim at inhibiting hyperactive signaling molecules, appear conceptually straight forward, but their translation into clinical practice has been hampered by many setbacks. Understanding...
Alternative Titles
Full title
Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70248912
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70248912
Other Identifiers
ISSN
0929-8673
E-ISSN
1875-533X
DOI
10.2174/092986707780059670
